CapitalG took part in a round that valued the cybersecurity software provider at $2bn and came just over a year after it was acquired for $1.1bn.

The round brought the total raised by the oncology diagnostics technology developer, backed by Bristol Myers Squibb, Helsinn and Inova Health, to $244m.

Existing strategic investor Allogene Therapeutics has taken part in an $85m series A round for Notch Therapeutics, which is working on cancer treatments.

Bloomberg Beta and GV are set to exit the data analytics technology developer in a $155m transaction that will follow about $33m in funding.

The probiotics developer secured an undisclosed amount as Cargill co-led the first close of a series D round with a $55m target.

Optum Ventures returned to invest in the telehealth software developer’s series A round, which was led by Venrock.

The Telus Ventures-backed debt recovery software provider has secured over $100m in total, Inovia Capital having led its series B-plus round.

The CBRE, Ericsson, AMD, News Corp, PTC and Qualcomm-backed spatial modelling technology provider will list on the Nasdaq Capital Market through the deal.

Total is set to score an exit from the fuel cell vehicle developer just four months on from its investment, through a reverse merger that will value Hyzon at $2.1bn once the deal closes.

Liberty Media, Union Square Hospitality and the NFL are the latest corporate investors to back the identity verification technology provider.